Followers | 102 |
Posts | 29035 |
Boards Moderated | 3 |
Alias Born | 09/17/2006 |
Wednesday, October 20, 2021 1:15:24 PM
RiceBran Technologies to Host Q3 2021 Financial Results Conference Call on October 27th, at 4:30 PM EST
https://greenstocknews.com/news/nasdaq/ribt/ricebran-technologies-to-host-q3-2021-financial-results-conference-call-on-october-27th-at-4-30-pm-est
RiceBran Technologies (NASDAQ:RIBT), a global leader in the development and production of critical nutritional and functional ingredients derived from small and ancient grains for the healthy food, nutraceutical, pet care and animal feed markets, announced that Peter Bradley, Executive Chairman and Todd Mitchell, Chief Financial Officer, will host a conference call on Wednesday, October 27th, at 4:30 p.m. EST to discuss the Company's financial results for the third quarter ended September 30, 2021.
The call information is as follows:
Date: October 27, 2021
Time: 4:30 p.m. Eastern Standard Time
Toll Free Dial-in number for US/Canada: 888-506-0062
Dial-In number for international callers: 973-528-0011
Participant Access Code: 603156
Webcast: https://www.ricebrantech.com/investors
Following the conclusion of the live call, a replay of the webcast will be available on the Investor Relations section of the Company's website for at least 90 days. A telephonic replay of the conference call will also be available from 7 p.m. EST on October 27, 2021 until 11:59 p.m. EST on November 10, 2021 by dialing 877-481-4010 (United States) or 919-882-2331 (international) and using the passcode 43350.
About RiceBran Technologies
RiceBran Technologies is a global leader in the production and marketing of value-added products derived from rice bran as well as a producer of rice, rice co-product, and barley and oat products. The target markets for our products include food and animal nutrition manufacturers and retailers, as well as specialty food, functional food and nutritional supplement manufacturers and retailers. Our highly nutritious and clean label ingredient products derived from rice bran, one of the world's most underutilized food sources, are produced utilizing our proprietary and patented stabilization technology. More information can be found in the Company's filings with the SEC and by visiting our website at http://www.ricebrantech.com.
Life is not measured by the number of breaths you take, but by the moments that take your breath away--Wows happen!!!
Recent RIBT News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/19/2024 08:25:57 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2024 01:43:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 10:01:09 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 07:36:17 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 02:51:19 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 01:28:01 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 01:05:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 01:58:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 01:53:02 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 09:26:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:24:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 08:06:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 01:07:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 12:55:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 09:25:14 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/31/2023 09:25:49 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/31/2023 09:22:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 09:14:16 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/24/2023 09:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:13:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:33:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2023 08:13:04 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM